RankAlpha logo
Back to Rankings

EOLS

EvolusB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
EOLS vs peer average
80/100
EOLS vs. peer average (B vs. D)
Grade spread
B 1 · C 2 · D 4 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AMGN is the first available peer comparator.

Large diversified biopharma benchmark; useful for sector risk appetite and scale context but not a direct aesthetics comparable.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAMGNAmgen
EOLS
Evolus
AMGN
Amgen
Grade
B
D
Momentum
95
72
Value
41
63
Sentiment
76
42
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs AMGN

EOLS / AMGN
Grade Position
Above peers
EOLS vs. peer average (B vs. D)
80/100
Momentum
95
EOLS
Value
41
AMGN
Sentiment
76
EOLS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs EOLS
1
AMGN
AMGN
D
40/100
+2
2
GILD
GILD
B
80/100
Even
3
CCCC
CCCC
C
60/100
+1
4
EVMN
Evommune Inc Common
F
20/100
+3
5
RLMD
Relmada Therapeutics Inc Common
C
60/100
+1
AMGN is the first peer returned for this comparison set.